Giuseppe Cullaro, Elizabeth C. Verna, Andres Duarte‐Rojo, Matthew R. Kappus, Daniel R. Ganger, Robert S. Rahimi, Brian Boyarsky, Dorry L. Segev, Mara McAdams‐DeMarco, Daniela P. Ladner, Michael L. Volk, Chi‐yuan Hsu, Jennifer C. Lai – 21 October 2021 – Acute kidney injury (AKI) and frailty are major drivers of outcomes among patients with cirrhosis. What is unknown is the impact of physical frailty on the development of AKI. We included adults with cirrhosis without hepatocellular carcinoma listed for liver transplantation at nine US centers (n = 1,033).

Tassos Grammatikopoulos, Nedim Hadzic, Pierre Foskett, Sandra Strautnieks, Marianne Samyn, Roshni Vara, Anil Dhawan, Jozef Hertecant, Fatma Al Jasmi, Obydur Rahman, University of Washington Center for Mendelian Genomics, Maesha Deheragoda, Laura N. Bull, Richard J Thompson – 21 October 2021 – Mutations in the transaldolase 1 (TALDO1) gene have been described in a limited number of cases. Several organs can be affected and clinical manifestations are variable, but often include liver dysfunction and/or hepatosplenomegaly.

Desley A. H. Neil, Marta Minervini, Maxwell L. Smith, Stefan G. Hubscher, Elizabeth M. Brunt, A. Jake Demetris – 21 October 2021

Marica Meroni, Miriam Longo, Rosa Lombardi, Erika Paolini, Chiara Macchi, Alberto Corsini, Cesare R. Sirtori, Anna Ludovica Fracanzani, Massimiliano Ruscica, Paola Dongiovanni – 21 October 2021 – Dyslipidemia and cardiovascular complications are comorbidities of nonalcoholic fatty liver disease (NAFLD), which ranges from simple steatosis to nonalcoholic steatohepatitis, fibrosis, and cirrhosis up to hepatocellular carcinoma.

Nobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, Nami Mori, Keiji Tsuji, Chitomi Hasebe, Kouji Joko, Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi, Hiroyuki Kimura, Hitoshi Yagisawa, Hiroyuki Marusawa, Masahiko Kondo, Yuji Kojima, Hideo Yoshida, Yasushi Uchida, Toshifumi Tada, Shinichiro Nakamura, Satoshi Yasuda, Hidenori Toyoda, Rohit Loomba, Namiki Izumi – 21 October 2021 – The identification of patients with advanced fibrosis who do not need any further hepatocellular carcinoma (HCC) surveillance after the eradication of hepatitis C is pivotal.

20 October 2021

20 October 2021

20 October 2021

20 October 2021

Alyson Kaplan, Robert S. Brown, Adam Buckholz, Thuy‐Van P. Hang, Preeti A. Reshamwala, Jessica L. Maiers, Robert E. Schwartz, Wei Zhang, Shalil Khanal, Enis Kostallari, Adebowale O. Bamidele, Amani Lee, Enis Kostallari, Mati Ullah Dad Ullah, Daryl T.Y. Lau, Davide Povero, Nabeel Wahid, Russell Rosenblatt – 20 October 2021